⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27533747 | 0.76 | — | — | |
| SCHEMBL65897 | 0.76 | — | — | |
| SCHEMBL65486 | 0.76 | — | — | |
| SCHEMBL1765946 | 0.76 | — | — | |
| Flucytosine SCHEMBL24063 | 0.76 | — | — | |
| SCHEMBL30609151 | 0.76 | — | — | |
| SCHEMBL1231792 | 0.76 | ATAD2 (0.37) | — | |
| SCHEMBL22008 | 0.76 | — | — | |
| Flucytosine SCHEMBL8160959 | 0.76 | ALDH1A1 (0.37) | — | |
| SCHEMBL10910615 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108727402-B | Oxaspiro bridged ureidopyrimidone compound and synthetic method thereof | 常州大学 | 2020-09-08 | — | — | CN | claimed |
| EP-0898575-B1 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KOESTER HUBERT DR (US) | 2004-12-29 | — | — | EP | claimed |
| US-20030194741-A1 | COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | CAPROTEC BIOANALYTICS GMBH (DE) | 2003-10-16 | — | — | US | claimed |
| US-20030054410-A1 | Combinatorial protecting group strategy for multifunctional molecules | CAPROTEC BIOANALYTICS GMBH (DE) | 2003-03-20 | — | — | US | claimed |
| EP-0898575-A2 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KÖSTER, Hubert (US) | 1999-03-03 | — | — | EP | claimed |
| WO-1997041139-A2 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KOESTER HUBERT (US) | 1997-11-06 | — | — | WO | claimed |
| JP-1113389-A | — | — | None | — | — | JP | disclosed |
| US-20250388903-A1 | Methods and Compositions for Adar-Mediated Editing | KORRO BIO INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250382610-A1 | RNA-EDITING OLIGONUCLEOTIDES AND USES THEREOF | KORRO BIO INC (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250352667-A1 | METHODS AND COMPOSITIONS FOR DISRUPTING NRF2-KEAP1 PROTEIN INTERACTION BY ADAR MEDIATED RNA EDITING | KORRO BIO INC (US) | 2025-11-20 | — | — | US | disclosed |
| US-12448620-B2 | RNA-editing oligonucleotides and uses thereof | KORRO BIO, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250215038-A1 | RNA-EDITING OLIGONUCLEOTIDES AND USES THEREOF | KORRO BIO, INC. | 2025-07-03 | — | — | US | disclosed |
| US-20250066773-A1 | RNA-EDITING OLIGONUCLEOTIDES AND USES THEREOF | KORRO BIO, INC. | 2025-02-27 | — | — | US | disclosed |
| US-4879377-A | Nucleoside process | BRISTOL-MYERS COMPANY (US) | 1989-11-07 | — | — | US | disclosed |
| WO-1989005649-A1 | ANTIVIRAL ANTITUMOR ANTIMETASTATIC IMMUNE SYSTEM ENHANCING NUCLEOSIDES AND NUCLEOTIDES | BRIGHAM YOUNG UNIVERSITY (US) | 1989-06-29 | — | — | WO | disclosed |
| JP-H01113389-A | PREPARATION OF FUSED PYRIDINE COMPOUND | UNIV PRINCETON | 1989-05-02 | — | — | JP | disclosed |
| EP-0145978-B1 | NUCLEOSIDE PROCESS | Bristol-Myers Company (US) | 1989-04-19 | — | — | EP | disclosed |
| US-4625020-A | Nucleoside process | BRISTOL-MYERS COMPANY (US) | 1986-11-25 | — | — | US | disclosed |
| EP-0145978-A2 | Nucleoside process | Bristol-Myers Company (US) | 1985-06-26 | — | — | EP | disclosed |
| US-3935184-A | Synthetic polyoxin type nucleosides | SYNTEX (U.S.A.) INC. (US) | 1976-01-27 | — | — | US | disclosed |